The withdrawal comes after postmarketing studies showed that the risks of side effects were greater than the benefits.

Pfizer withdraws OXBRYTA after post marketing studies showed that the risks of side effects were greater than the benefits.

Officials hosted a tour Friday and launched a groundbreaking pediatric treatment for sickle cell disease. Yunigen officials, including Chief Executive Officer and Vice President Charles Otieno and ...

Current health news includes the declaration of a public health emergency in Georgia due to Hurricane Helene, the slow uptake ...

September is sickles cell awareness month. One Chicago woman who was diagnosed at birth is raising funds and awareness with a ...

Meanwhile, in Lawton, about a dozen people showed up at the Abundant Life Christian Church to donate blood for the Sickle ...

Health care organizations continue to caution that there’s a need for blood donors to keep the emergency blood supply stable ...

Beam Therapeutics' pipeline shows promise but remains in early stages with no clinical trial data yet available. Find out why ...

The RUBY Trial is showing promise in treating patients fighting sickle cell disease, and Ohio is setting a national standard ...

September is Sickle Cell Awareness month.While the month itself is almost over, patients living with the disease face a daily ...

This summary of current health news includes FDA approvals for new drugs by Bristol Myers and GE HealthCare, public health ...

Sickle cell disease is a painful, inherited condition that primarily impacts African Americans. Dr. Sharl Azar, medical ...